Transphorm, Inc. (NASDAQ:TGAN) Sees Large Growth in Short Interest

Transphorm, Inc. (NASDAQ:TGANGet Free Report) was the recipient of a large growth in short interest during the month of February. As of February 29th, there was short interest totalling 637,900 shares, a growth of 33.8% from the February 14th total of 476,900 shares. Based on an average daily volume of 414,800 shares, the days-to-cover ratio is currently 1.5 days. Approximately 1.3% of the shares of the company are short sold.

Institutional Investors Weigh In On Transphorm

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Northern Trust Corp grew its stake in shares of Transphorm by 1.5% during the 4th quarter. Northern Trust Corp now owns 224,846 shares of the company’s stock worth $821,000 after purchasing an additional 3,379 shares during the period. Charles Schwab Investment Management Inc. grew its stake in shares of Transphorm by 14.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 84,217 shares of the company’s stock worth $187,000 after purchasing an additional 10,831 shares during the period. Vanguard Group Inc. grew its stake in shares of Transphorm by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 1,480,319 shares of the company’s stock worth $5,403,000 after purchasing an additional 15,477 shares during the period. Barclays PLC grew its stake in shares of Transphorm by 635.0% during the 4th quarter. Barclays PLC now owns 40,519 shares of the company’s stock worth $148,000 after purchasing an additional 35,006 shares during the period. Finally, Worth Venture Partners LLC grew its stake in shares of Transphorm by 4.6% during the 3rd quarter. Worth Venture Partners LLC now owns 1,152,278 shares of the company’s stock worth $2,558,000 after purchasing an additional 50,598 shares during the period.

Wall Street Analyst Weigh In

Separately, Benchmark reaffirmed a “hold” rating on shares of Transphorm in a research report on Tuesday, January 16th.

Check Out Our Latest Stock Report on Transphorm

Transphorm Price Performance

TGAN traded up $0.02 during trading on Friday, reaching $4.90. 320,146 shares of the company’s stock were exchanged, compared to its average volume of 509,407. Transphorm has a 1 year low of $1.94 and a 1 year high of $5.10. The stock has a market capitalization of $310.05 million, a P/E ratio of -7.10 and a beta of 0.58. The company’s fifty day simple moving average is $4.79 and its 200-day simple moving average is $3.45.

Transphorm (NASDAQ:TGANGet Free Report) last posted its quarterly earnings results on Tuesday, February 20th. The company reported ($0.20) earnings per share (EPS) for the quarter. Transphorm had a negative return on equity of 149.03% and a negative net margin of 177.91%. The business had revenue of $4.67 million for the quarter.

Transphorm Company Profile

(Get Free Report)

Transphorm, Inc, a semiconductor company, develops, manufactures, and sells gallium nitride (GaN) semiconductor components for high voltage power conversion applications in Mainland China, Hong Kong, Taiwan, the United States, Japan, South Korea, India, and Europe. The company's products include GaN field effect transistors in various packages.

Recommended Stories

Receive News & Ratings for Transphorm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transphorm and related companies with MarketBeat.com's FREE daily email newsletter.